Exemestane Versus Tamoxifen
tranSMART Community Meeting 5-7 Nov 13 - Session 3: transmart’s application to clinical biomarker discovery in sanofi
Elke Sennewald, 22 September 2011 Trial Design Introduction.
1 Results of the first planned analysis of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive.
Trial Design in the CDISC World
Trial Design in the CDISC World Albert Chau 26 July 2011 1.
Elke Sennewald , 22 September 2011
